Biotechnology in Israel

The research committee headed by the chief scientist at TMT: biotechnology and nanotechnology - preferred fields

Ivogen and Compugen will test the production of human proteins in wild tomatoes

A scientist from the Weizmann Institute and a scientist from the Technion were selected for the list of "XNUMX leading young scientists in the world"

Compugen announces a scientific breakthrough: a fifth nucleic acid in RNA is more common than known

Compugen establishes Kedem Biosciences, a subsidiary for the discovery of small molecules for pharmaceutical purposes

The hot innovations of Biotech Israel 2004 week

Minister of Science: Israel is five years behind in examining applications for patents in the field of biotechnology

An Israeli company has developed a tiny robot dentist. Raises 4 million dollars

Compugen and Tel Aviv University discovered a unique prediction method

Clinical trials have begun for a drug designed to treat Alzheimer's

When the molecular stem is cut, the drugs fall from the branches and begin to work

18 Israeli companies in the field of life sciences were closed in 2003

Soothes the skin

Prof. Michel Rebel: The issue of biotechnology and bioinformatics in Israel is essential for the economy

Compugen enters the DNA chip production market; Celera offered the Israeli government to buy the use of

Biotechnology: a budget ten times larger will produce companies a hundred times larger

Give me a cough suppressant

And we will go live to the small intestine

Who owns the rights to the human genome?

The fantastic journey in the human body

Biotechnology companies fear the publication of the first draft of the human genome

Biotechnology in Israel

The research committee headed by the chief scientist at TMT: biotechnology and nanotechnology - preferred fields

Ivogen and Compugen will test the production of human proteins in wild tomatoes

A scientist from the Weizmann Institute and a scientist from the Technion were selected for the list of "XNUMX leading young scientists in the world"

Compugen announces a scientific breakthrough: a fifth nucleic acid in RNA is more common than known

Compugen establishes Kedem Biosciences, a subsidiary for the discovery of small molecules for pharmaceutical purposes

The hot innovations of Biotech Israel 2004 week

Minister of Science: Israel is five years behind in examining applications for patents in the field of biotechnology

An Israeli company has developed a tiny robot dentist. Raises 4 million dollars

Compugen and Tel Aviv University discovered a unique prediction method

Clinical trials have begun for a drug designed to treat Alzheimer's

When the molecular stem is cut, the drugs fall from the branches and begin to work

18 Israeli companies in the field of life sciences were closed in 2003

Soothes the skin

Prof. Michel Rebel: The issue of biotechnology and bioinformatics in Israel is essential for the economy

Compugen enters the DNA chip production market; Celera offered the Israeli government to buy the use of

Biotechnology: a budget ten times larger will produce companies a hundred times larger

Give me a cough suppressant

And we will go live to the small intestine

Who owns the rights to the human genome?

The fantastic journey in the human body

Biotechnology companies fear the publication of the first draft of the human genome

most read in the last month

More information